Kyowa Kirin announced it is discontinuing all ongoing clinical trials for rocatinlimab, an investigational anti-OX40 monoclonal antibody, after a safety review identified “emerging concerns” of ...

Jacob Becraft is the co-founder and CEO of Strand Therapeutics. In the late 20th century, the United States made a bet that it could offshore manufacturing to countries with cheaper labor, such as ...

This March, join the Alliance for Clinical Trials in Oncology (Alliance) and the Alliance Foundation Trials (AFT) in ...

Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...

It's yet another perk of these medications.

New research suggests that weight loss drugs GLP-1s could help the heart heal after a heart attack. Here's exactly how.

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one ...

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Cognitive psychology research on the Zeigarnik effect explains why unresolved relationship endings cause compulsive ...

Researchers led by Mass General Brigham report that older adults who took a daily multivitamin for two years showed signs of ...

The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients ...